Metabolic Crosstalk in Multimorbidity: Identifying Compensatory Effects Among Diabetes, Hypertension, and Dyslipidemia

Author:

Pitti Erica1,Vanni Domitilla1ORCID,Viceconte Nicola2,Lembo Angelo1ORCID,Tanzilli Gaetano2ORCID,Raparelli Valeria3ORCID,Petrella Greta1ORCID,Cicero Daniel O1ORCID

Affiliation:

1. Department of Chemical Science and Technology, University of Rome “Tor Vergata,”   00133 Rome , Italy

2. Department of Cardiovascular, Respiratory, Nephrological, Anesthesiologic and Geriatric Sciences, Sapienza University of Rome, Policlinic Umberto I , 00161 Rome , Italy

3. Department of Translational and Precision Medicine, Sapienza University of Rome , 00185 Rome , Italy

Abstract

Abstract Context Metabolomics is becoming increasingly popular for detecting markers that indicate the presence of a specific disease. However, it is usually applied to studying individual ailments, yielding results that may not be directly relevant to people with multiple health conditions. Objective Our study proposes a different approach to explore metabolic crosstalk between various disease states. Design, Setting, and Patients We conducted a study on subjects at medium to high risk of developing coronary artery disease. We measured the plasma levels of 83 metabolites using nuclear magnetic resonance and analyzed the connections between these metabolites and various risk factors such as diabetes, hypertension, and dyslipidemia. Linear regression and multivariate analysis were combined for this purpose. Results Inspection of the metabolic maps created by our analysis helped us efficiently compare profiles. In this way, it was possible to discover opposing metabolic features among single conditions and their combination. Furthermore, we found compensating metabolic effects between diabetes, hypertension, and dyslipidemia involving mainly ketone body metabolism and fatty acid β-oxidation. Conclusion Our study introduces a novel approach to investigating how metabolism reacts to the simultaneous presence of multiple health conditions. This has allowed the detection of potential compensatory effects between diabetes, hypertension, and dyslipidemia, highlighting the complexity of metabolic crosstalk in patients with comorbidities. A better understanding of metabolic crosstalk like this could aid in developing focused treatments, resulting in improved therapeutic results.

Funder

Collezione Nazionale di Composti Chimici e Centro Screening

Publisher

The Endocrine Society

Reference58 articles.

1. Metabolic analysis as a driver for discovery, diagnosis and therapy;DeBerardinis;Cell,2022

2. Critical roles of functional molecule metabolites;Liu;Front Mol Biosci,2023

3. Small molecule metabolites: discovery of biomarkers and therapeutic targets;Qiu;Signal Transduct Target Ther,2023

4. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis;Rahman Chowdhury;EClinicalMedicine,2023

5. Randomized controlled trials: do they have external validity for patients with multiple comorbidities?;Fortin;Ann Fam Med,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3